Company Profile
Kodiak Sciences Stock Price, News & Catalysts
- Ticker:
- KOD
- Exchange:
- NASDAQ
- Sector:
- Biopharma
- Location:
- United States
Stock performance
37.22 USD (-2.90%)
Close
Last updated: August 24, 2026
2.08B USD
Market cap
Why the stock is moving
As of Aug 24, 2026, KOD closed down 2.90% at $37.22. No new same-company headline was identified in the current news window.
Company overview
Business overview
Kodiak Sciences is a retinal-disease company focused on ophthalmology and long-duration eye therapies. Its story has been shaped by the challenge of building a differentiated retina franchise.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ, Kodiak sits in specialty ophthalmology biotechnology.
Business Model Characteristics
The company depends on clinical data, delivery strategy, and the ability to create a durable retinal-disease platform.
Position Within the Biotechnology Landscape
Kodiak is a high-beta eye-care name with strong sensitivity to data and execution risk.
Future catalysts
- Kodiak is now mostly a legacy and transaction-closeout name, so the catalysts are any final ophthalmology or strategic milestones that clarify remaining value. The market is not treating it like a fresh growth story anymore.
Recent news
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Kodiak Sciences (KOD)?
Kodiak Sciences (KOD) most recently closed at 37.22 USD, a -2.90% move versus the previous session.
What is the market cap of Kodiak Sciences (KOD)?
Kodiak Sciences currently has a market capitalization of 2.08B USD on BioPharmSignal.
What does Kodiak Sciences do?
Kodiak Sciences is a retinal-disease company focused on ophthalmology and long-duration eye therapies. Its story has been shaped by the challenge of building a differentiated retina franchise.
On which exchange is KOD stock listed?
Kodiak Sciences (KOD) is associated with NASDAQ, United States, Biopharma.
What is Kodiak?
Kodiak is now mostly a legacy and transaction-closeout name, so the catalysts are any final ophthalmology or strategic milestones that clarify remaining value.
Which conditions is Kodiak Sciences targeting with Kodiak?
Kodiak Sciences is associated with ophthalmology based on its company overview and current catalyst commentary.
How does Kodiak Sciences describe recent progress with Kodiak?
Kodiak is now mostly a legacy and transaction-closeout name, so the catalysts are any final ophthalmology or strategic milestones that clarify remaining value.
What is Sciences?
Kodiak Sciences is a retinal-disease company focused on ophthalmology and long-duration eye therapies.